Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Jubilant Pharmova Financial Results

Jubilant Pharmova reported audited FY26 financial results and recommended a 500% final dividend of ₹5 per share. Totaling ₹79.6 Crore, payment follows shareholder approval.

Key figures
Value₹79.60 Cr
Source

BSE filing, NSE: JUBLPHARMA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Jubilant Pharmova Ltd: key numbers

Share price
₹943.90
Market cap
₹15,035 Cr
Revenue (annual)
₹8,280 Cr
Net profit (annual)
₹398.5 Cr
P/E (TTM)
42.7×Sector 46.1×
Promoter holding
47.68%+0.00% QoQ
FII holding
15.37%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Jubilant Pharmova Ltd

All →

Other financial results announcements

All →